180 related articles for article (PubMed ID: 35989082)
1. Rosai-Dorfman-Destombes disease - histiocytic disorder with inflammatory manifestation.
Adam Z; Adamová Z; Pour L; Řehák Z; Koukalová R; Král Z
Klin Onkol; 2022; 35(4):262-170. PubMed ID: 35989082
[TBL] [Abstract][Full Text] [Related]
2. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.
Abla O; Jacobsen E; Picarsic J; Krenova Z; Jaffe R; Emile JF; Durham BH; Braier J; Charlotte F; Donadieu J; Cohen-Aubart F; Rodriguez-Galindo C; Allen C; Whitlock JA; Weitzman S; McClain KL; Haroche J; Diamond EL
Blood; 2018 Jun; 131(26):2877-2890. PubMed ID: 29720485
[TBL] [Abstract][Full Text] [Related]
3. [Histiocytosis of Rosai-Dorfman-Destombes extranodal of the jawbone: Report of a case and review of the literature].
Vaquier L; Abitbol C; Emile JF; Dossier A; Guyard A; Hourseau M
Ann Pathol; 2022 Apr; 42(3):264-268. PubMed ID: 35033363
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of cases of Rosai Dorfman disease reported on the African continent and a description of two cases from a tertiary academic hospital in Johannesburg, South Africa.
Laudin GE; Lakha AB; Dullabh N; Mohanlal R; Jassat R; Waja MF; Philip V
Pan Afr Med J; 2023; 45():130. PubMed ID: 37790150
[TBL] [Abstract][Full Text] [Related]
5. How I Diagnose Rosai-Dorfman Disease.
Ravindran A; Rech KL
Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
[TBL] [Abstract][Full Text] [Related]
6. [Cutaneous Rosai-Dorfman disease with lack of BRAF-V600, KRAS or NRAS mutations: A reactive or neoplastic disorder?].
Machado I; Alcacer Fernández-Coronado J; Requena C; Través V; Latorre Martínez N; Ortega J; Requena L; Alcacer García J
Rev Esp Patol; 2022; 55(1):52-56. PubMed ID: 34980442
[TBL] [Abstract][Full Text] [Related]
7. [Rosai-Dorfman-Destombes disease with a misleading laryngeal presentation].
Fiani DJ; Émile JF; Istier L; Boutin AB; Tychyj C; Benzerdjeb N; Donzel M; Balme B; Traverse-Glehen A; Fontaine J
Ann Pathol; 2022 Nov; 42(6):475-480. PubMed ID: 36038429
[TBL] [Abstract][Full Text] [Related]
8. Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.
Shanmugam V; Margolskee E; Kluk M; Giorgadze T; Orazi A
Head Neck Pathol; 2016 Sep; 10(3):394-9. PubMed ID: 26922062
[TBL] [Abstract][Full Text] [Related]
9. Rosai-Dorfman Disease between Proliferation and Neoplasia.
Elbaz Younes I; Sokol L; Zhang L
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358690
[TBL] [Abstract][Full Text] [Related]
10. [Rosai-Dorfman disease: Diagnosis and therapeutic challenges].
Cohen Aubart F; Haroche J; Emile JF; Charlotte F; Barete S; Schleinitz N; Donadieu J; Amoura Z
Rev Med Interne; 2018 Aug; 39(8):635-640. PubMed ID: 29501513
[TBL] [Abstract][Full Text] [Related]
11. Multiple Drug Regimen-Refractory Rosai-Dorfman-Destombes Disease Mimicking Relapsing Polychondritis Successfully Treated with Cobimetinib.
López-Aldabe K; Escrihuela-Vidal F; Tuells-Morales M; Llobera-Ris C; Bauer-Alonso A; Cortes-Romera M; Gràcia-Sànchez L; Tormo-Ratera M; Juanola Roura X; Penin-Mosquera RM; Corbella X; Solanich X
Eur J Case Rep Intern Med; 2022; 9(2):003076. PubMed ID: 35265540
[TBL] [Abstract][Full Text] [Related]
12. [Benign histiocytosis: Rosai-Dorfman disease].
Noordzij W; Weernink EE; van Imhoff GW; Kluin PM; de Haan LD
Ned Tijdschr Geneeskd; 2011; 155(27):A3176. PubMed ID: 21771370
[TBL] [Abstract][Full Text] [Related]
13. A rare presentation of Rosai-Dorfman-Destombes disease with central nervous system involvement and cutaneous wounds.
Workman L; Fang L; Ayoub S; Bach K; Simman R
J Wound Care; 2024 May; 33(Sup5):S10-S13. PubMed ID: 38683815
[TBL] [Abstract][Full Text] [Related]
14. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.
Garces S; Medeiros LJ; Patel KP; Li S; Pina-Oviedo S; Li J; Garces JC; Khoury JD; Yin CC
Mod Pathol; 2017 Oct; 30(10):1367-1377. PubMed ID: 28664935
[TBL] [Abstract][Full Text] [Related]
15. ROSE in Rosai-Dorfman-Destombes (RDD) disease: a cytological diagnosis.
Tummidi S; Singh HK; Reddy PA; Sindhura M; Kosaraju N; Shankaralingappa A; Kumar NP
Eur J Med Res; 2021 Apr; 26(1):34. PubMed ID: 33849657
[TBL] [Abstract][Full Text] [Related]
16. Isolated intracranial rosai-dorfman disease involving the meninges: report of a rare case.
Bhat A; Kupanur SS; Geethamani V
Turk Neurosurg; 2015; 25(1):186-9. PubMed ID: 25640569
[TBL] [Abstract][Full Text] [Related]
17. [Rosai-Dorfman disease: clinicopathologic, immunohistochemical and etiologic study of 16 cases].
Yu JB; Liu WP; Zuo Z; Tang Y; Liao DY; Ji H; Bai YQ; Li SH; Lu CQ; Luo HB
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):33-8. PubMed ID: 17374236
[TBL] [Abstract][Full Text] [Related]
18. Rosai-Dorfman disease in the central nervous system with two isolated lesions originated from a single clone: a case report.
Jin H; Yu Z; Tian T; Shen G; Chen W; Fan M; He Q; Xu F; Liu D
BMC Neurol; 2021 Sep; 21(1):352. PubMed ID: 34517832
[TBL] [Abstract][Full Text] [Related]
19. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
[TBL] [Abstract][Full Text] [Related]
20. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
